The short treatment with IFNβ1a was able to reverse memory impairment and to suppress microglia activation and the upregulation of pro-inflammatory cytokine (IL-6, IL-1β) levels and oxidative stress in the hippocampus. This evidence concerns the gene IL6 and memory impairment.